PLx Pharma, Inc. (NASDAQ:PLXP)

About the company

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. It offers PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Sparta, NJ.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

12

CEO

Natasha Giordano

Exchange

NASDAQ

Website

http://www.plxpharma.com

$0.00M

Total Revenue

12

Employees

$27.00M

Market Capitalization

-2.86

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12030.90 1376.00 5.13 18.97 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7525.41 4837.00 1.29 51.34 3.02
Bausch Health Cos., Inc. BHC 6195.15 8597.00 8.65 -3.27 -21.96
Jazz Pharmaceuticals Plc JAZZ 6129.78 2188.00 2.12 22.40 12.81
United Therapeutics Corp. UTHR 5064.54 1443.00 1.76 9.77 36.59
MyoKardia, Inc. MYOK 4325.84 34.00 12.57 -13.95 -201.73
Axsome Therapeutics, Inc. AXSM 3004.40 None 20.39 -33.40 None
Pacira Biosciences, Inc. PCRX 2275.14 435.00 6.10 -5417.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2181.92 9.00 2.56 -3.37 -413.06
Corcept Therapeutics, Inc. CORT 2054.48 335.00 4.72 19.36 31.64
Prestige Consumer Healthcare, Inc. PBH 1862.52 963.00 1.57 13.14 14.77
Madrigal Pharmaceuticals, Inc. MDGL 1617.30 0.00 4.32 -15.83 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1595.90 440.00 -22.59 18.82 19.14
Revolution Medicines, Inc. RVMD 1567.34 48.00 4.07 -22.14 -146.29
Innoviva, Inc. INVA 1539.06 285.00 3.64 7.96 66.41
Intercept Pharmaceuticals, Inc. ICPT 1409.60 272.00 -41.95 -4.11 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Zogenix, Inc. ZGNX 1272.60 5.00 3.47 -2.99 -241.62
Revance Therapeutics, Inc. RVNC 1230.46 0.00 4.86 -6.59 41.82
Theravance Biopharma, Inc. TBPH 1136.58 88.00 -7.98 -4.61 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1053.50 327.00 2.63 20.67 15.90
Endo International Plc ENDP 777.48 3014.00 -1.06 -2.77 -9.09
BellRing Brands, Inc. BRBR 771.22 954.00 -0.42 5.85 13.98
Assembly Biosciences, Inc. ASMB 693.39 16.00 3.11 -6.97 -601.75
Eagle Pharmaceuticals, Inc. EGRX 648.90 192.00 3.49 257.50 1.29
Aerie Pharmaceuticals, Inc. AERI 641.70 79.00 5.09 -3.17 -252.92
Collegium Pharmaceutical, Inc. COLL 581.06 299.00 4.16 -44.97 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 543.56 119.00 5.29 12.39 36.09
Anika Therapeutics, Inc. ANIK 494.20 125.00 1.71 17.83 22.73
Intersect ENT, Inc. XENT 445.76 102.00 4.21 -8.93 -48.61
BioDelivery Sciences International, Inc. BDSI 392.84 130.00 5.62 -53.37 -5.01
ANI Pharmaceuticals, Inc. ANIP 367.56 203.00 1.88 -235.62 -0.67
Albireo Pharma, Inc. ALBO 332.41 11.00 3.38 -4.35 -730.55
MEI Pharma, Inc. MEIP 284.69 5.00 4.90 -7.30 -539.48
Mallinckrodt Plc MNK 199.08 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 163.43 None 2.66 -7.91 None
Marinus Pharmaceuticals, Inc. MRNS 161.60 0.00 6.26 -2.40 None
Cerecor, Inc. CERC 120.75 7.00 7.72 -5.36 -429.22
Ampio Pharmaceuticals, Inc. AMPE 95.81 1.00 67.00 -5.15 None
CTI BioPharma Corp. CTIC 91.45 3.00 4.08 -2.21 -111.83
AcelRx Pharmaceuticals, Inc. ACRX 87.20 2.00 -1.60 -1.56 -644.25
Evoke Pharma, Inc. EVOK 86.88 None 30.17 -12.93 None
Zynerba Pharmaceuticals, Inc. ZYNE 78.66 0.00 1.29 -2.19 -699.94
Adamas Pharmaceuticals, Inc. ADMS 71.96 57.00 -4.59 -0.78 -160.44
Aclaris Therapeutics, Inc. ACRS 68.88 4.00 1.21 -0.50 None
Oramed Pharmaceuticals, Inc. ORMP 60.48 3.00 4.87 -4.73 -464.15
Cassava Sciences, Inc. SAVA 59.28 41.00 3.12 -13.00 76.71
Cumberland Pharmaceuticals, Inc. CPIX 49.65 47.00 1.01 -11.03 -9.59
SCYNEXIS, Inc. SCYX 48.95 0.00 10.28 -1.26 -30.84
Natural Alternatives International, Inc. NAII 47.11 114.00 0.65 -12.46 -3.19
IsoRay, Inc. ISR 42.88 9.00 8.00 -12.80 -36.08
Lipocine, Inc. LPCN 39.60 0.00 9.43 -2.64 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 27.00 0.00 -2.59 -2.86 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.80 3.00 2.59 -1.76 -264.21
Regulus Therapeutics, Inc. RGLS 17.64 0.00 1.56 -0.82 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.66 None 1.37 -0.25 None
VIVUS, Inc. VVUS 8.88 73.00 -0.20 -0.30 -39.28
Hepion Pharmaceuticals, Inc. HEPA 7.38 None 2.31 -0.62 None
Sonoma Pharmaceuticals, Inc. SNOA 6.37 19.00 1.01 -2.04 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Tonix Pharmaceuticals Holding Corp. TNXP 4.27 None 1.07 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

BRIEF-Plx Pharma Inc Files For Shelf Of Up To 2.6 Million Shares By Selling Stockholders - SEC Filing

8d ago, source: Reuters

PLX PHARMA INC FILES FOR SHELF OF UP TO 2.6 MILLION SHARES BY SELLING STOCKHOLDERS - SEC FILING Source text for Eikon: bit.ly/2NEsuib Further company coverage: Our Standards:The Thomson Reuters Trust ...

PLx Pharma Inc. Announces Completion of $8 Million Convertible Preferred Stock Financing

1mon ago, source: YAHOO!

SPARTA, N.J., May 18, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically ...

Hedge Funds Cautiously Watching PLx Pharma Inc. (PLXP)

1mon ago, source: YAHOO!

In this article you are going to find out whether hedge funds think PLx Pharma Inc. (NASDAQ:PLXP) is a good investment right now. We like to check what the smart money thinks first before doing ...

PLx Pharma Inc.

27d ago, source: MarketWatch

06/22/2017 N/A SC 13G/A Institutional Ownership * 06/19/2017 N/A SC 13G Institutional Ownership 05/01/2017 N/A SC 13G Institutional Ownership 02/14/2017 N/A SC 13G/A Institutional Ownership * 02 ...

PLXP PLx Pharma Inc. Common Stock

27d ago, source: Nasdaq

©2019, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR ...

BRIEF-Plx Pharma Inc Files For Shelf Of Up To 2.6 Million Shares By Selling Stockholders - SEC Filing

8d ago, source: Reuters

June 30 (Reuters) - PLx Pharma Inc: * PLX PHARMA INC FILES FOR SHELF OF UP TO 2.6 MILLION SHARES BY SELLING STOCKHOLDERS - SEC FILING Source text for Eikon: bit.ly/2NEsuib Further company coverage ...

PLx Pharma Inc. Announces Completion of $8 Million Convertible Preferred Stock Financing

1mon ago, source: GlobeNewswire

May 18, 2020 16:30 ET | Source: PLx Pharma Inc. SPARTA, N.J., May 18, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.